Oculis Holding AG (OCS) Selling, General & Administrative (2022 - 2026)

Oculis Holding AG (OCS) Selling, General & Administrative (2022 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Alterity Therapeutics 814,307.08 Bn 814,307.05 Bn - -
2 Belite Bio 55,320.00 Bn 55,320.00 Bn - 17.02 Mn
3 Quantum Biopharma 17,149.72 Bn 17,149.72 Bn - 1.32 Mn
4 Legend Biotech 3,590.00 Bn 3,589.71 Bn 242.10 Mn -37.00 Mn
5 Akari Therapeutics 1,650.72 Bn 1,650.72 Bn - 2.17 Mn
6 Evaxion A 1,522.09 Bn 1,522.07 Bn - -1.52 Mn
7 Psyence Biomedical 229.39 Bn 229.38 Bn - 217,225.00
8 Vertex Pharmaceuticals 113.09 Bn 105.85 Bn 2.59 Bn 493.70 Mn
9 Abivax 90.15 Bn 90.15 Bn - -7.36 Mn
10 Oculis Holding AG 8.23 Bn 7.92 Bn - -10.08 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -10.08 Mn
Dec 31, 2025 -9.70 Mn
Sep 30, 2025 -8.03 Bn
Jun 30, 2025 -7.39 Mn
Mar 31, 2025 -6.10 Mn
Dec 31, 2024 -6.28 Mn
Sep 30, 2024 -6.17 Bn
Jun 30, 2024 -6.93 Mn
Mar 31, 2024 -5.38 Mn
Dec 31, 2023 -4.89 Mn
Sep 30, 2023 -4.88 Mn
Jun 30, 2023 -5.34 Mn
Mar 31, 2023 -4.37 Mn
Dec 31, 2022 -4.61 Mn
Sep 30, 2022 -2.57 Mn
Jun 30, 2022 -2.88 Mn